Adjuvant 5‐Fluorouracil/leucovorin, capecitabine, and oxaliplatin‐related regimens for stage II/III colon cancer patients 66 years or older

Adjuvant chemotherapy of leucovorin‐modulated 5‐fluorouracil (5‐FU/LV), capecitabine, and adding oxaliplatin to 5‐FU/LV or capecitabine (FLOX/OX) have been standard regimens for high‐risk stage II or III colon cancer (CC). We aimed to evaluate their patterns of use, association with survival, and ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Emily, Duan, Zhigang, Nguyen, Thinh T., Giordano, Sharon H., Zhao, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939133/
https://www.ncbi.nlm.nih.gov/pubmed/36229957
http://dx.doi.org/10.1002/cam4.5078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939133/
https://www.ncbi.nlm.nih.gov/pubmed/36229957
http://dx.doi.org/10.1002/cam4.5078

Ejemplares similares